Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Rat dog micro-cap picks... -- Ignore unavailable to you. Want to Upgrade?

To: Bucky Katt who wrote (30506)	7/14/2006 1:51:04 AM
From: ~digs	Read Replies (2) \| Respond to of 48461

Nice looking hammer for CRYO on Thursday Here's the news behind the move in MSS ... Thursday July 13, 11:44 am ET --Milestone Scientific Inc., which develops, manufactures, and markets 'intelligent' computer controlled local anesthetic delivery systems, today announced that it has received FDA 510(k) Premarket Notification acceptance for the marketing and sale of its CompuFlo(TM) Computer Controlled Infusion Pump. biz.yahoo.com

To: Bucky Katt who wrote (30506)	7/24/2006 10:21:10 AM
From: Tamer	Respond to of 48461

BK, Thanks for posting your scan results. RE: SSPI There is no change in the story. They have had two recent press releases regarding their product being chosen again and again as a component for the development of new products and technologies by other companies. This morning’s release involves Motorola. As they continue to become involved in these kinds of deals the real money should come with actual production agreements. These current news releases have not resulted in any follow through in volume or price. This morning's lack of action is a good example. The stock is a true dog. I think an actual production agreement with one or more of these heavy hitters would generate good volume and result in a nice pop. Of course the questions continue to be will a contract come and will the company still be around when it comes. Earnings and conference call next week.